Compare PAHC & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PAHC | TWST |
|---|---|---|
| Founded | 1946 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2014 | 2018 |
| Metric | PAHC | TWST |
|---|---|---|
| Price | $40.78 | $31.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 8 |
| Target Price | $31.25 | ★ $44.88 |
| AVG Volume (30 Days) | 273.3K | ★ 1.4M |
| Earning Date | 02-04-2026 | 02-02-2026 |
| Dividend Yield | ★ 1.18% | N/A |
| EPS Growth | ★ 288.74 | N/A |
| EPS | ★ 1.67 | N/A |
| Revenue | ★ $1,399,676,000.00 | $376,572,000.00 |
| Revenue This Year | $15.34 | $15.19 |
| Revenue Next Year | $3.28 | $15.10 |
| P/E Ratio | $24.30 | ★ N/A |
| Revenue Growth | ★ 33.72 | 20.32 |
| 52 Week Low | $16.16 | $23.30 |
| 52 Week High | $46.42 | $55.33 |
| Indicator | PAHC | TWST |
|---|---|---|
| Relative Strength Index (RSI) | 48.75 | 54.42 |
| Support Level | $39.39 | $30.21 |
| Resistance Level | $41.62 | $33.31 |
| Average True Range (ATR) | 1.66 | 1.81 |
| MACD | -0.02 | 0.07 |
| Stochastic Oscillator | 63.50 | 62.68 |
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.